Patents by Inventor Richard Sackler

Richard Sackler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20190046522
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: October 12, 2018
    Publication date: February 14, 2019
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
    Patent number: 10028947
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: July 24, 2018
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing irritant
    Patent number: 10022369
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: July 17, 2018
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
    Publication number: 20170354654
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Application
    Filed: July 10, 2017
    Publication date: December 14, 2017
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
    Patent number: 9737529
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: August 22, 2017
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20170173000
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: March 3, 2017
    Publication date: June 22, 2017
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20170119756
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 4, 2017
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing irritant
    Patent number: 9511065
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: December 6, 2016
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
    Publication number: 20160263103
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 15, 2016
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
    Patent number: 9326954
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: May 3, 2016
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20150366861
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: September 1, 2015
    Publication date: December 24, 2015
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing irritant
    Patent number: 9155717
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: October 13, 2015
    Assignee: Purdue Pharma L. P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20140155426
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: January 7, 2014
    Publication date: June 5, 2014
    Applicant: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
    Publication number: 20140155425
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Application
    Filed: December 23, 2013
    Publication date: June 5, 2014
    Applicant: PURDUE PHARMA L.P.
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing irritant
    Patent number: 8652497
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: February 18, 2014
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent
    Patent number: 8652515
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: February 18, 2014
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT
    Publication number: 20120201761
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Application
    Filed: September 12, 2011
    Publication date: August 9, 2012
    Applicant: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
    Patent number: 8017148
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising: a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and an irritant in an effective amount to impart an irritating sensation to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: September 13, 2011
    Assignee: Purdue Pharma L.P.
    Inventor: Richard Sackler
  • PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
    Publication number: 20100261713
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 14, 2010
    Applicant: Purdue Pharma L.P.
    Inventor: Richard SACKLER
  • Method of treating humans with opioid formulations having extended controlled release
    Patent number: 7740881
    Abstract: Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24 hours, have a dissolution rate in-vitro of the dosage form, when measured by the USP Paddle Method at 100 rpm at 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37° C. of from about 12.5% to about 42.5% (by wt) opioid released after 1 hour, from about 25% to about 65% (by wt) opioid released after 2 hours, from about 45% to about 85% (by wt) opioid released after 4 hours, and greater than about 60% (by wt) opioid released after 8 hours, the in-vitro release rate being substantially independent of pH and chosen such that the peak plasma level of said opioid analgesic obtained in-vivo occurs from about 2 to about 8 hours after administration of the dosage form.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: June 22, 2010
    Assignee: Purdue Pharma LP
    Inventors: Richard Sackler, Robert Kaiko, Paul Goldenheim